Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab in Metabolic Bone Disease in Chronic Intestinal Failure
NCT02853539Phase 4Completed
- Sponsor
- Stanley Dudrick Memorial Hospital
- Start
- Jan 2011
- Primary completion
- Jul 2016
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in metabolic bone disease (MBD), sponsored by Stanley Dudrick Memorial Hospital. Started Jan 2011; status: completed.
02
Drugs
denosumab
03
Conditions
metabolic bone disease (MBD)
Beyond the preview
Go deeper on NCT02853539.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02853539.